IDRI Strategic Collaboration Fund 2023 (SCF)

Background

The Strategic Collaboration Fund (SCF) is a new funding awarded by the Infectious Diseases Research Institute (IDRI) to aid strategic and innovative clinical research in infectious diseases in Singapore. It also hopes to form SingHealth Duke-NUS Academic Medical Centre (AMC) wide Focus Groups in strategic areas within specific infectious diseases research themes.
　
The Strategic Collaboration Fund (SCF) aims to support, facilitate and encourage pilot inter-institutional collaborative research projects, between early stage investigators of SingHealth Institutions in Infectious Diseases and of Duke-NUS, Emerging Infectious Diseases (EID) programme.

The joint collaborative research activity should meet one or more of the following purposes:

• Form a core functional unit/work group/common interest group between SingHealth Institutions and Duke-NUS EID programme;
• Provide pilot data or a platform to launch or advance innovative new research projects that meet the broad goals of IDRI in particular to the below listed research focus areas;
• Facilitate partnership between researchers from SingHealth Institutions and Duke-NUS EID programme;
• Develop and strengthen Cross Institutional Collaboration and Cross Disciplinary Collaboration among the partnering entities.

Funding Details

Funding per award is capped at S$50,000 per project for a maximum duration of 2 years.

Eligibility Criteria

• Each proposal must involve a demonstrable research collaboration between the researchers from SingHealth and the EID programme, Duke-NUS. The research team must include at least one investigator from SingHealth and one from EID, Duke NUS - of whom one must be the PI. The other shall serve as a Co-I. There is no limit to the no. of Co-I or collaborators on a given (single) application.

• PIs should hold a primary appointment in institutions under SingHealth or EID, Duke-NUS and salaried by the host Institution.

• This joint collaborative research opportunity should demonstrate participation and contributions at all levels; scientific, technical and administrative etc., from investigators based at both SingHealth Institutions and EID, Duke-NUS.

• The proposals shall be within the research focus areas as listed (Research Focus Areas).

• The IDRI SCF is targeted at Early Stage Investigators. Investigators with extensive and significant research experience may be included as mentors or supervisors but not as PI's.

Submission

1. Applicants are to submit their completed applications using the application form by 21 July 2023, 5pm. Each applicant can only submit one application per SCF grant call as the PI.

2. Application must be endorsed prior to the submission to SingHealth Office of Research (OoR) through the Research Office of the PI’s Host Institution to IDRI Manager at simi.issac@singhealth.com.sg.

3. Only applications with following submissions received will be accepted:
   
4. • 2 soft copies containing all information (such as images, tables, charts and all other attachments)
   • (1 in word format without signatures and 1 in PDF format with signatures).　Electronic signatures are allowed.
     
5. Endorsement required for:
6. • SingHealth PI: Head of Department (HOD) and Research Director
   • EID, Duke-NUS PI: Programme Director (EID, Duke-NUS) and Senior Vice Dean Research (Duke-NUS)
     
     Please note: If the HOD/Research Director/Duke correlate is involved in the project (as Co-Investigator or Collaborator), his or her supervisor is required to endorse the application instead.

Contact person

Ms Simi Issac　
Email: simi.issac@singhealth.com.sg

Additional information

SCF 2023 Application Form.docx

SCF 2023 Application Guidelines.pdf